Skip to main content


Digital Twin


Inaccurate medications kill 5 times more than road accidents in developed countries. Jus in France, they cost 10 billion euros to the public health system. Around the globe, consolidated numbers are not easily accessible but we estimate that inaccurate medications cause at least 1 million deaths and cost 1000 billion dollars to public health systems every year. We are facing a massive global challenge.

Our Digital Twin simulates the efficacy of medicines in your body based on your personal characteristics.

ExactCure is a pioneer startup offering a software solution to reduce the impact of inaccurate medication.
Our Digital Twin simulates in silico the efficacy and interactions of medicines in the body of a patient based on his/her personal characteristics. We help the patient to avoid under-doses, overdoses and drug interactions. His/her health professionals can potentially follow him/her remotely in real time.
Our solutions results from years of fundamental research in bio-modeling with Inria, a tier-1 French fundamental research institute. It is certified as a Medical Device.

Our solution is a unique double innovation:

1 • Usage Innovation: the patient can predict and visualize the activity of his/her medication and is thus empowered.

2 • Technological Innovation: our Artificial Intelligence is able to simulate the influence of personal characteristics such as age, weight, gender, kidney status, ... on the effectiveness and interactions of drugs for a given patient. Our Machine Learning algorithms can also continuously adjust bio-models based on the qualitative feedback of patients.

Our Mission is to empower patients by providing them with bio-modeling tools to visualize the effects of drugs within their bodies. 
Our Vision is to live in a world where each individual has access to a personalized medicine.
Our Ambition is to become the world leader in personalized bio-modeling of medicines within 5 years.


Our solution leverages proprietary algorithms that will be powered by the 3DEXPERIENCE platform. In particular, our complex workflows will benefit from the BIOVIA Pipeline Pilot backbone. Indeed, we need a strong and robust calculation and data management process in order to ensure that we deliver the best service to patients and health professionals.



If a patient shares his/her personalized simulations, health professionals will have the possibility to remotely monitor the effect of drugs in his/her body and receive relevant alerts. This way doctors and pharmacists will have a collaborative tool to improve global health.

Besides, we will build a database allowing a more precise understanding of the influence of drugs on one's body based on individual characteristics. As a consequence, drugs prescriptions will collectively become more accurate and iatrogeny will decrease.

Meet the team

Solidly built upon benevolence and trust, our team also believes that creativity can spur from fun!

  • Frederic Dayan
    Frederic Dayan
    Co-founder & CEO
  • Sylvain Benito
    Sylvain Benito
    Co-founder & Chief Scientist Officer
  • Fabien Astic
    Fabien Astic
    Co-founder & Chief Business Officer
  • Julien Welzel
    Julien Welzel
    R&D Director
  • Matthieu Basset
    Matthieu Basset
    Data Scientist & Pharmacist
  • Aurélie Lereclus
    Aurélie Lereclus
    Research Engineer
  • Maika Warita
    Maika Warita
    Data Scientist

Similar projects

Submit your project

Do you think your project is the next big thing?
Join the team !

Submit your project